Navigation Links
Hormonal Changes in Girls Increase Their Risk of Insomnia

A study was conducted by Dr. Eric O. Johnson and his colleagues found that hormonal changes play a role in the development of insomnia (sleep disorder) after girls begin menstruation. //

The participants included more than 1,000 girls between the age group of 13- to 16 years old. It was surprising to find that about 11 % of them suffer from insomnia. Insomnia can be clinically defined as difficulty in falling asleep or staying asleep at least four times per week for one month or longer.

On an average it was found that the teens had sleep disturbances around the age of 11. After menstrual periods girls were at more than twice the risk of insomnia as boys.

The findings were published in the journal Pediatrics. Johnson, a researcher with RTI International in Research Triangle Park, North Carolina also suggests another reason for girls to have an increased risk of insomnia after menstruation.

He said that it could be due to the physical changes that come with puberty, like breast development, that may contribute to sleep problems. There are two types of sleep problems one is to have problems with staying asleep and getting enough deep sleep due to physiological causes which is associated with menstruation.

The other is related to problems with falling asleep in the first place caused due to stress-related factors.

Another vital finding is that girls having higher risk of insomnia had higher rates of depression, which is often marked by sleep disturbances.

About 88 % showed such symptoms at the time of the study. Hence the research team concluded by saying that Insomnia is a common and chronic problem among adolescents.

This results in blunted mental acuity, poor performance in the school and poorer physical and emotional health. Hence this has to be prevented and proper treatment should be administered.


'"/>




Page: 1

Related medicine news :

1. Viagra Halves Effect Of Hormonal Stress On Heart
2. Hormonal Changes Causes Older Women To Have Twins
3. Non Hormonal Therapies for Menopause Not Proved to be Effective
4. Non-Hormonal Male Contraceptive Based on Sperm Block Underway
5. Medication Abuse In Chronic Migraine May Cause Hormonal Abnormalities
6. Herceptin + Hormonal Therapy Pack Reduces Breast Cancer Progression
7. Stress – Buster : Hormonal Nasal Spra
8. Males too Undergoes Hormonal Changes During Parenting: Study
9. Combination of Herceptin and Hormonal therapy to Fight Cancer
10. Male Contraceptive Drug - Non Hormonal Alternative
11. NIMH Studies Woman’s Hormonal Cycl
Post Your Comments:
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
Breaking Medicine News(10 mins):Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Human guinea pigs wary of high-paying medical trials 2
...tudy of its kind, a Mexican health care program cr... crippling health care costs among poorer househol...Popular program, and arise from an evaluation cond... establish that the program achieved its main goal...
...th in Long-Term Survivors of Hereditary Retinoblas...stoma are at an increased risk of death due to a s... Retinoblastoma is a very rare cancer of the eye ...he risk of death due to these subsequent cancers i...
...te have found that the growth factor known as TGF-... in the retina and that blocking it can cause reti...April 2 issue of PLoS ONE , may have an important...hey add to our understanding of the molecules that...
...ement of these growths needs to be tailored , ...e cancer cell can lead to multiple, anatomically d...e types of tumors usually look similar, but, until...dy by a team at the Indiana University School of M...
...e interventions in future, study finds , ,...ve treatment in the first two years after a diagno...ove patient survival, a new study finds. , Researc...ceived the most intensive treatment was $7,131 com...
...nd should be urged, expert says, , , TUESD...of moderate exercise will not harm people with hea... a new study has found. , That admittedly tepid co...e. , Some were started on a 36-session training pr...
Other Medicine News:Health News:Mexican health care program successful at reducing crippling health care costs 2Health News:Mexican health care program successful at reducing crippling health care costs 3Health News:Also in the April 7 JNCI 2Health News:Also in the April 7 JNCI 3Health News:Also in the April 7 JNCI 4Health News:Growth factor TGF-B helps maintain health of retinal blood vessels 2Health News:Single Cell May Produce Multiple Lung Cancer Tumors 2Health News:Intensive Early Treatment Doesn't Help Bladder Cancer Survival 2Health News:Exercise Might Benefit Some With Heart Failure 2Health News:Exercise Might Benefit Some With Heart Failure 3
(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred 4865 1Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred 4865 2Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred 4865 3The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 1The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 2The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 3The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 4The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 5Laureate Pharma Elects New Board Member 13606 1Laureate Pharma Elects New Board Member 13606 2
...nced Cancer Patients, ROCKVILLE, Md., April 9, 20...age pharmaceutical company developing,therapeutics...ases, today,announced that it has commenced a Phas...e inhibitor, ENMD-2076, in advanced cancer patient...ancer Center, will serve as,co-principal investiga...
...tivity of CR011-vcMMAE for ...results to be presented in June at 2008 ASCO ... Conn., April 9, 2008 CuraGen,Corporation (Nasdaq...any,focused on oncology, announced today that it h...te (ADC), into Phase II for the treatment of patie...
Other Medicine Technology:EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program 2EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program 3EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program 4CuraGen Advances CR011-vcMMAE into Phase II 2CuraGen Advances CR011-vcMMAE into Phase II 3CuraGen Advances CR011-vcMMAE into Phase II 4
MONOJECT Red/Yellow Mottled Stopper
MONOJECT Black Stopper
VACUETTE Paediatric Fluoride Tubes - Ridged (safety screw cap)
BD Vacutainer® Fluoride Tubes - Plastic
Medicine Products: